Literature DB >> 26979915

Seizures in patients with primary brain tumors: what is their psychosocial impact?

John Y Shin1, Sani H Kizilbash2, Steven I Robinson2, Joon H Uhm2,3, Julie E Hammack3, Daniel H Lachance3, Jan C Buckner2, Aminah Jatoi4.   

Abstract

Seizures occur in most patients with primary malignant tumors and are associated with poor quality of life. To our knowledge, no previous studies have sought descriptions of quality of life in patients' own words. Patients with a history of a malignant primary brain tumor and seizures participated in semi-structured interviews, which were analyzed with qualitative methodology. Twenty-seven patients participated, most with high grade brain tumors. Most were receiving anti-seizure medication. Three distinct themes emerged: (1) the first seizure as a sentinel event, as manifested in part by how patients described their first seizure in remarkable detail ("I clearly remember the date…"); (2) seizures as inextricably tied to the brain tumor itself; for example, one patient explained how he "always wondered what was happening with my brain tumor" with each seizure; and (3) adaptation and acceptance-or lack therefore-to seizures. With respect to this third theme, patients conveyed frustration from an inability to work, to drive, and to take care of their children ("It's like you are 15 all over again.") Others described frustration with taking antiseizure medications ("I felt like an 80 year old, now taking her pills every day"). However, some patients had adapted or resigned themselves ("…so much of life is out of control-you just gotta take what you get."). These findings have future research implications but should also serve to make healthcare providers more aware of the heavy emotional burden that seizures thrust upon brain tumor patients.

Entities:  

Keywords:  Brain tumors; Qualitative; Quality of life; Seizures; Symptoms

Mesh:

Substances:

Year:  2016        PMID: 26979915     DOI: 10.1007/s11060-016-2108-y

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  28 in total

Review 1.  Qualitative research in health care. Analysing qualitative data.

Authors:  C Pope; S Ziebland; N Mays
Journal:  BMJ       Date:  2000-01-08

2.  The development of a financial toxicity patient-reported outcome in cancer: The COST measure.

Authors:  Jonas A de Souza; Bonnie J Yap; Fay J Hlubocky; Kristen Wroblewski; Mark J Ratain; David Cella; Christopher K Daugherty
Journal:  Cancer       Date:  2014-06-20       Impact factor: 6.860

3.  Impact of late effects on health-related quality of life in survivors of pediatric brain tumors: motility disturbance of limb(s), seizure, ocular/visual impairment, endocrine abnormality, and higher brain dysfunction.

Authors:  Iori Sato; Akiko Higuchi; Takaaki Yanagisawa; Shiho Murayama; Toshihiro Kumabe; Kazuhiko Sugiyama; Akitake Mukasa; Nobuhito Saito; Yutaka Sawamura; Mizuhiko Terasaki; Soichiro Shibui; Jun Takahashi; Ryo Nishikawa; Yasushi Ishida; Kiyoko Kamibeppu
Journal:  Cancer Nurs       Date:  2014 Nov-Dec       Impact factor: 2.592

Review 4.  Rigour and qualitative research.

Authors:  N Mays; C Pope
Journal:  BMJ       Date:  1995-07-08

5.  Development and Validation of a Disease-Specific Instrument to Measure Diet-Targeted Quality of Life for Postoperative Patients with Esophagogastric Cancer.

Authors:  Michitaka Honda; Takafumi Wakita; Yoshihiro Onishi; Souya Nunobe; Akinori Miura; Tatsuto Nishigori; Hiroshi Kusanagi; Takatsugu Yamamoto; Alexander Boddy; Shunichi Fukuhara
Journal:  Ann Surg Oncol       Date:  2015-06-30       Impact factor: 5.344

6.  What distinguishes top-performing hospitals in acute myocardial infarction mortality rates? A qualitative study.

Authors:  Leslie A Curry; Erica Spatz; Emily Cherlin; Jennifer W Thompson; David Berg; Henry H Ting; Carole Decker; Harlan M Krumholz; Elizabeth H Bradley
Journal:  Ann Intern Med       Date:  2011-03-15       Impact factor: 25.391

Review 7.  A review of the symptomatic management of malignant gliomas in adults.

Authors:  Umang Shah; Tara Morrison
Journal:  J Natl Compr Canc Netw       Date:  2013-04-01       Impact factor: 11.908

8.  Efficacy of anti-epileptic drugs in patients with gliomas and seizures.

Authors:  Mèlanie S M van Breemen; R M Rijsman; M J B Taphoorn; R Walchenbach; H Zwinkels; Charles J Vecht
Journal:  J Neurol       Date:  2009-05-12       Impact factor: 4.849

9.  Phase III development of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire module for women undergoing breast reconstruction.

Authors:  Z E Winters; V Balta; H J Thomson; Y Brandberg; A Oberguggenberger; Y Sinove; D Unukovych; M Nava; K Sandelin; H Johansson; J Dobbeleir; P Blondeel; N Bruno; G Catanuto; R Llewellyn-Bennett
Journal:  Br J Surg       Date:  2014-01-29       Impact factor: 6.939

10.  Development and evaluation of a new survey instrument to measure the quality of colorectal cancer screening decisions.

Authors:  Karen R Sepucha; Sandra Feibelmann; Carol Cosenza; Carrie A Levin; Michael Pignone
Journal:  BMC Med Inform Decis Mak       Date:  2014-08-20       Impact factor: 2.796

View more
  8 in total

1.  Epilepsy education in gliomas: engaging patients and caregivers to improve care.

Authors:  Andrea Wasilewski; Jennifer Serventi; Chinazom Ibegbu; Thomas Wychowski; Joy Burke; Nimish Mohile
Journal:  Support Care Cancer       Date:  2019-07-02       Impact factor: 3.603

2.  Expression changes in ion channel and immunity genes are associated with glioma-related epilepsy in patients with diffuse gliomas.

Authors:  Lianwang Li; Chuanbao Zhang; Zheng Wang; Yuhao Guo; Yinyan Wang; Xing Fan; Tao Jiang
Journal:  J Cancer Res Clin Oncol       Date:  2022-05-18       Impact factor: 4.322

Review 3.  Clinical practice guidelines for the diagnosis and treatment of adult diffuse glioma-related epilepsy.

Authors:  Shuli Liang; Xing Fan; Ming Zhao; Xia Shan; Wenling Li; Ping Ding; Gan You; Zhen Hong; Xuejun Yang; Guoming Luan; Wenbin Ma; Hui Yang; Yongpin You; Tianming Yang; Liang Li; Weiping Liao; Lei Wang; Xun Wu; Xinguang Yu; Jianguo Zhang; Qing Mao; Yuping Wang; Wenbin Li; Xuefeng Wang; Chuanlu Jiang; Xiaoyan Liu; Songtao Qi; Xingzhou Liu; Yan Qu; Jiwen Xu; Weimin Wang; Zhi Song; Jinsong Wu; Zhixiong Liu; Ling Chen; Yuanxiang Lin; Jian Zhou; Xianzeng Liu; Wei Zhang; Shichuo Li; Tao Jiang
Journal:  Cancer Med       Date:  2019-06-26       Impact factor: 4.452

4.  Seizure outcome in temporal glioblastoma surgery: lobectomy as a supratotal resection regime outclasses conventional gross-total resection.

Authors:  Matthias Schneider; Patrick Schuss; Valeri Borger; Motaz Hamed; Inja Ilic; Anna-Laura Potthoff; Attila Racz; Niklas Schäfer; Erdem Güresir; Rainer Surges; Ulrich Herrlinger; Hartmut Vatter
Journal:  J Neurooncol       Date:  2021-02-07       Impact factor: 4.130

Review 5.  Sociocognitive Functioning and Psychosocial Burden in Patients with Brain Tumors.

Authors:  Milena Pertz; Uwe Schlegel; Patrizia Thoma
Journal:  Cancers (Basel)       Date:  2022-02-01       Impact factor: 6.639

6.  Acute care in glioblastoma: the burden and the consequences.

Authors:  Andrea Wasilewski; Jennifer Serventi; Lily Kamalyan; Thomas Wychowski; Nimish Mohile
Journal:  Neurooncol Pract       Date:  2017-03-08

7.  New-Onset Postoperative Seizures in Patients With Diffuse Gliomas: A Risk Assessment Analysis.

Authors:  Lianwang Li; Guanzhang Li; Shengyu Fang; Kenan Zhang; Ruoyu Huang; Yinyan Wang; Chuanbao Zhang; Yiming Li; Wei Zhang; Zhong Zhang; Qiang Jin; Dabiao Zhou; Xing Fan; Tao Jiang
Journal:  Front Neurol       Date:  2021-06-18       Impact factor: 4.003

8.  Radiomics Analysis of Postoperative Epilepsy Seizures in Low-Grade Gliomas Using Preoperative MR Images.

Authors:  Kai Sun; Zhenyu Liu; Yiming Li; Lei Wang; Zhenchao Tang; Shuo Wang; Xuezhi Zhou; Lizhi Shao; Caixia Sun; Xing Liu; Tao Jiang; Yinyan Wang; Jie Tian
Journal:  Front Oncol       Date:  2020-07-08       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.